Corticosteroids do not alter the threshold for vertebral fracture

Area of Science:

• Endocrinology
• Bone Metabolism
• Rheumatology

Background:

• Corticosteroids are a leading secondary cause of osteoporosis.
• It is hypothesized that corticosteroids impair bone quality, leading to fractures at lower bone mineral density (BMD) than expected.
• This study investigates the relationship between BMD and vertebral fractures in corticosteroid users versus non-users.

Purpose of the Study:

• To determine if corticosteroid therapy alters the relationship between bone mineral density (BMD) and vertebral fracture risk.
• To compare fracture prevalence and severity in patients on corticosteroids versus those not on steroids.
• To assess if current diagnostic criteria for osteoporosis are appropriate for patients using corticosteroids.

Main Methods:

• Retrospective analysis of 452 patients with BMD measurements and thoracolumbar radiographs.
• Comparison of BMD and vertebral fracture rates between 82 patients on corticosteroids and 370 patients without steroid exposure.
• Analysis of fracture prevalence, multiplicity, and BMD T-scores in relation to steroid use.

Main Results:

• No significant difference in BMD was observed between patients on corticosteroids and controls.
• Vertebral fractures were more prevalent (53% vs. 35%) and more likely to be multiple in patients on corticosteroids.
• The median BMD for fractures was marginally lower in steroid users (-2.74) compared to non-users (-2.65), but this did not support an altered fracture threshold.

Conclusions:

• The findings do not support the hypothesis that long-term corticosteroid use alters the bone density fracture threshold.
• The same diagnostic criteria for osteoporosis should be applied to patients regardless of corticosteroid use.
• Corticosteroid-induced osteoporosis management should focus on BMD and fracture risk assessment using standard guidelines.